Antibodies.com raises £400,000 in pre-seed financing to help scientists discover more for less

Antibodies.com, a digital marketplace that enables life scientists to purchase critical research reagents at cost-effective prices from the primary manufacturers, today announced that is has raised £400,000 in pre-seed financing. Nidobirds Ventures, after successful investment in Labstep, joined local angel investors and industry veterans in the funding round. The funds will be used by Antibodies.com to expand its catalog of off-the-shelf reagents, implement new sales and marketing programs to drive customer acquisition, and scale its proprietary AI assisted “Product Matching” tool.

Antibodies.com enables researchers to source reliable antibodies, proteins, and immunoassays up to 5x faster and 75% cheaper than current methods. This is especially important as roughly 50% of research antibodies simply don’t work in experiments; this wastes billions of dollars of funding and countless hours each year, ultimately: slowing down studies, wasting research samples, and delaying treatments from getting to patients.

The company launched out of beta in May 2018 and has since gone from strength to strength. Antibodies.com now works with 50+ supply chain partners, offers 70,000+ research reagents, and operates across North America and Europe. Customers now include some of the world’s largest pharmaceutical companies (including Glaxo Smith Kline, Glenmark Pharmaceuticals, and Merck & Co) and leading academic research institutions (including MIT, Standard University, University of Cambridge, and University of Oxford).

Today’s fundraise is a key milestone for Antibodies.com. We bootstrapped Antibodies.com from inception and accomplished a great deal of product validation, market traction, and growth. This pre-seed round enables us to significantly expand our operations and will help us achieve our vision of helping researchers discover more, for less”.

Sebastian Newlove, co-founder of Antibodies.com & former bench scientist

Paul Carter, senior procurement officer, commented:

The University of Manchester is delighted to welcome Antibodies.com as a life science research tool supplier. Their wide range of low cost and high quality reagents will really help support our research”.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Antibodies.com. (2019, July 02). Antibodies.com raises £400,000 in pre-seed financing to help scientists discover more for less. News-Medical. Retrieved on October 15, 2019 from https://www.news-medical.net/news/20190702/Antibodiescom-raises-c2a3400000-in-pre-seed-financing-to-help-scientists-discover-more-for-less.aspx.

  • MLA

    Antibodies.com. "Antibodies.com raises £400,000 in pre-seed financing to help scientists discover more for less". News-Medical. 15 October 2019. <https://www.news-medical.net/news/20190702/Antibodiescom-raises-c2a3400000-in-pre-seed-financing-to-help-scientists-discover-more-for-less.aspx>.

  • Chicago

    Antibodies.com. "Antibodies.com raises £400,000 in pre-seed financing to help scientists discover more for less". News-Medical. https://www.news-medical.net/news/20190702/Antibodiescom-raises-c2a3400000-in-pre-seed-financing-to-help-scientists-discover-more-for-less.aspx. (accessed October 15, 2019).

  • Harvard

    Antibodies.com. 2019. Antibodies.com raises £400,000 in pre-seed financing to help scientists discover more for less. News-Medical, viewed 15 October 2019, https://www.news-medical.net/news/20190702/Antibodiescom-raises-c2a3400000-in-pre-seed-financing-to-help-scientists-discover-more-for-less.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News-Medical.Net.
Post a new comment
Post